Ifrs Statement Line Items

No definition available.

Name:	ck0001537137_IfrsStatementLineItems
Namespace Prefix:	ck0001537137_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average exercise price of share options exercisable in share based payment arrangements.

+ References

No definition available.

+ Details

Name:	ck0001537137_WeightedAverageExercisePriceOfShareOptionsExercisableInShareBasedPaymentArrangements
Namespace Prefix:	ck0001537137_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The exercise price of outstanding share options.

+ References

+ Details

Name:	ifrs-full_ExercisePriceOfOutstandingShareOptions2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of share options outstanding in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard
-URIDate 2025-03-27

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard
-URIDate 2025-03-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard
-URIDate 2025-03-27

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard
-URIDate 2025-03-27

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_NumberOfOutstandingShareOptions
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of share options exercisable in a share-based payment arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2025-01-01
-Paragraph 45
-Subparagraph b
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vii&doctype=Standard
-URIDate 2025-03-27

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vii&doctype=Standard
-URIDate 2025-03-27

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Note Effective 2027-01-01
-Name IFRS
-Number 19
-IssueDate 2025-01-01
-Paragraph 31
-Subparagraph b
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vii&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]

+ References

+ Details

Name:	ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]

+ References

+ Details

Name:	ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

Share Capital - Options by Exercise Price (Details)	6 Months Ended
Share Capital - Options by Exercise Price (Details)	Jun. 30, 2026 Equityinstruments $ / shares	Dec. 31, 2025 Equityinstruments	Jun. 30, 2025 $ / shares
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 3.23		$ 1.4
Number of Shares, Options Outstanding \| Equityinstruments	12,161,679	11,678,698
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	2 years 11 months 12 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 2.46
Number Exercisable, Options Exercisable \| Equityinstruments	7,462,899
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 2.8
4.78
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 4.78
Number of Shares, Options Outstanding \| Equityinstruments	200,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	18 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 4.78
Number Exercisable, Options Exercisable \| Equityinstruments	200,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 4.78
4.94
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 4.94
Number of Shares, Options Outstanding \| Equityinstruments	200,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	8 months 4 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 4.94
Number Exercisable, Options Exercisable \| Equityinstruments	200,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 4.94
6.52
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 6.52
Number of Shares, Options Outstanding \| Equityinstruments	170,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	8 months 15 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 6.52
Number Exercisable, Options Exercisable \| Equityinstruments	170,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 6.52
7.45
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 7.45
Number of Shares, Options Outstanding \| Equityinstruments	100,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	9 months 10 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 7.45
Number Exercisable, Options Exercisable \| Equityinstruments	100,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 7.45
3.77
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 3.77
Number of Shares, Options Outstanding \| Equityinstruments	2,690,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	1 year 9 months 10 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 3.77
Number Exercisable, Options Exercisable \| Equityinstruments	2,690,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 3.77
3.85
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 3.85
Number of Shares, Options Outstanding \| Equityinstruments	150,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	1 year 10 months 24 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 3.85
Number Exercisable, Options Exercisable \| Equityinstruments	150,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 3.85
2.97
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 2.97
Number of Shares, Options Outstanding \| Equityinstruments	750,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	2 years 2 months 26 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 2.97
Number Exercisable, Options Exercisable \| Equityinstruments	583,332
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 2.97
1.07
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 1.07
Number of Shares, Options Outstanding \| Equityinstruments	100,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	2 years 9 months 18 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.07
Number Exercisable, Options Exercisable \| Equityinstruments	75,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.07
1.13
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 1.13
Number of Shares, Options Outstanding \| Equityinstruments	1,063,394
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	3 years 1 month 9 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.13
Number Exercisable, Options Exercisable \| Equityinstruments	354,465
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.13
1.36
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 1.36
Number of Shares, Options Outstanding \| Equityinstruments	2,000,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	3 years 2 months 4 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.36
Number Exercisable, Options Exercisable \| Equityinstruments	1,333,334
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.36
1.42
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 1.42
Number of Shares, Options Outstanding \| Equityinstruments	863,852
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	3 years 5 months 19 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.42
Number Exercisable, Options Exercisable \| Equityinstruments	487,951
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.42
1.35
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 1.35
Number of Shares, Options Outstanding \| Equityinstruments	1,598,853
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	3 years 8 months 26 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.35
Number Exercisable, Options Exercisable \| Equityinstruments	732,951
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.35
1.27
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 1.27
Number of Shares, Options Outstanding \| Equityinstruments	557,599
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	3 years 9 months
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.27
Number Exercisable, Options Exercisable \| Equityinstruments	185,866
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.27
1.78
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 1.78
Number of Shares, Options Outstanding \| Equityinstruments	300,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	3 years 11 months 23 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.78
Number Exercisable, Options Exercisable \| Equityinstruments	100,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 1.78
2.92
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 2.92
Number of Shares, Options Outstanding \| Equityinstruments	250,000
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	4 years 1 month 20 days
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 2.92
Number Exercisable, Options Exercisable \| Equityinstruments	100,000
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 2.92
3.23
Share Capital
Weighted Average Exercise Price, Options Outstanding (in USD per share)	$ 3.23
Number of Shares, Options Outstanding \| Equityinstruments	1,167,981
Weighted Average Remaining Contractual Life, Options Outstanding (Year)	4 years 9 months
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 3.23
Weighted Average Exercise Price, Options Exercisable (in USD per share)	$ 3.23